Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: T3
There is absolutely no way TPL will be able to command top dollar for an MMP license unless a public message is sent to the industry and courts via a publicized settlement or trial victory. Any sealed settlements will imply we negotiated from a weak position. Maybe gcduck can get some insight as to what shareholders can expect. GLTAL
Share
New Message
Please login to post a reply